DOI: http://dx.doi.org/10.18203/2349-3933.ijam20161076

Restless leg syndrome as co-morbidity in type 2 diabetes mellitus

Akash Rajender, Gaurav R., Krishna Kanwal, R. S. Chaudhri, Deepa C., Priyanka Choudhary, Mona N.

Abstract


Background: Diabetes is a global epidemic with India estimated to have the highest prevalence of 79.4 million by 2030. RLS is a common yet undiagnosed comorbidity causing significant distress. We aimed to analyze association between restless legs syndrome (RLS) and type 2 diabetes.

Methods: One hundred fifty six type 2 diabetes mellitus (T2DM) and eighty eight non-diabetic controls were assessed at Mahatma Gandhi Medical College & Hospital, Jaipur, India for RLS using the international RLS study group rating scale. Several patient clinical profiles along with laboratory parameters were compared in both groups. Diabetic polyneuropathy was evaluated for its role as risk factor in diabetic RLS subjects.

Results: RLS was diagnosed in 35 diabetic patients (22.44%) and in only 7 non diabetic controls (7.95%). RLS was independently associated with type 2 diabetes (P<0.04). A clinical diagnosis of polyneuropathy was made in only 22.86% of diabetic patients with comorbid RLS. In multivariate logistic regression, polyneuropathy was the only variable associated with RLS in diabetics (P<0.03). RLS manifested in diabetics after the diagnosis of diabetes was made.

Conclusions: An association between RLS and type 2 diabetes is established in Indian subpopulation. In diabetic patients, polyneuropathy is the main risk factor for RLS. But, polyneuropathy only partially explains the increased prevalence of RLS in type 2 diabetics.


Keywords


RLS, Type 2 diabetes, Polyneuropathy

Full Text:

PDF

References


O’Keeffe ST, Gavin K, Lavan JN. Iron status and restless legs syndrome in the elderly. Age Ageing. 1994;23:200-3.

Gigli GL, Adorati M, Dolso P, Piani A, Valente M, Brotini S et al. Restless legs syndrome in endstage renal disease. Sleep Med. 2004;5(3):309-15.

Manconi M, Govoni V, De Vito A et al. Restless legs syndrome and pregnancy. Neurology 2004;63:1065-9.

Rutkove SB, Matheson JK, Logigian EL. Restless legs syndrome in patients with polyneuropathy. Muscle Nerve. 1996;19:670-2.

Salih AM, Gray RE, Mills KR, Webley M. A clinical, serological and neurophysiological study of restless legs syndrome in rheumatoid arthritis. Br J Rheumatol. 1994;33:60-3.

Allen RP, Picchietti D, Hening WA, Trenkwalder C, Walters AS, Montplaisir J. Restless legs syndrome diagnosis and epidemiology workshop at the national institutes of health in collaboration withmembers of the international restless legs syndrome study group. restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. a report from the restless legs syndrome diagnosis and epidemiology workshop at the national institutes of health. Sleep Med. 2003;4:101-19.

Walters AS, LeBrocq C, Dhar A, Dhar A, Hening W, Rosen R, Allen RP, et al. Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome. Sleep Med. 2003;4(2):121-32.

Ondo W, Jankovic J. Restless legs syndrome: clinicoetiologic correlates. Neurology. 1996;47:1435-41.

England JD, Gronseth GS, Franklin G, Miller RG, Asbury AK, Carter GT, et al; American Academy of Neurology; American Association of Electrodiagnostic Medicine; American Academy of Physical Medicine and Rehabilitation. Distal symmetric polyneuropathy: a definition for clinical research: report of the American Academy of Neurology, the American Association of Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation. Neurology 2005;64(2):199-207.

Meijer JW, SMit AJ, Lefrandt JD, van der Hoeven JH, Hoogenberg K, Links TP. Back to basics in diagnosing diabetic polyneuropathy with tuning fork! Diabetes Care. 2005;28:2201-5.

Zucconi M, Ferini-Strambi L. Epidemiology and clinical findings of restless legs syndrome. Sleep Med. 2004;5:293-9.

Skomro RP, Ludwig S, Salamon E, Kryger MH. Sleep complaints and restless legs syndrome in adult type 2 diabetics. Sleep Med. 2001;2:417-22.

Lopes LA, Lins Cde M, Adeodato VG, Quental DP, de Bruin PF, Montenegro RM Jr, et al. Restless legs syn-drome and quality of sleep in type 2 diabetes. Diabetes Care. 2005;28(11):2633-6.

Roger SD, Harris DC, Stewart JH. Possible relation between rest-less legs syndrome and anaemia in renal dialysis patients. Lancet. 1991;337:1551.

Gallego M, Setien R, Izquierdo MJ, Casis O, Casis E. Diabetes-induced biochemical changes in central and peripheral catecholaminergic systems. Physiol Res. 2003;52:735-41.

Ondo WG, He Y, Rajasekaran S, Le WD. Clinical correlates of 6-hydroxydopamine injections into A11 dopaminergic neurons in rats: a possible model for restless legs syndrome. Mov Disord. 2000;15:154-8.

Qu S, Ondo WG, Zhang X, Xie WJ, Pan TH, Le WD. Projections of diencephalic dopamine neurones into the spinal cord in mice. Exp Brain Res. 2006;168:152-6.

Jensen TS, Smith DF. Dopaminergic effects on tail-flick response in spinal rats. Eur J Pharmacol. 1982;79:129-33.

Handwerker HO, Iggo A, Zimmermann M. Segmental and supraspinal actions on dorsal horn neurons responding to noxious and non-noxious skin stimuli. Pain. 1975;1:147-65.

Winkelmann J, Wetter TC, Collado-Seidel V, Gasser T, Dichgans M, Yassouridis A, et al. Clinical characteristics and frequency of the hereditary restless legs syndrome in a population of 300 patients. Sleep 2000;23(5):597-602.

Merlino G, Piani A, Dolso P, Adorati M, Cancelli I, Valente M, et al. Sleep disorders in patients with end-stage renal disease undergoing dialysis therapy. Nephrol Dial Transplant 2006;21(1):184-90.

Kripke DF, Garfinkel L, Wingard DL, Klauber MR, Marler MR. Mortality associated with sleep duration and insomnia. Arch Gen Psychiatry. 2002;59:131-6.

Elwood P, Hack M, Pickering J, Hughes J, Gallacher J. Sleep disturbance, stroke, and heart disease events: evidence from the Caerphilly cohort. J Epidemiol Community Health. 2006;60:69-73.

Gangwisch JE, Heymsfield SB, Boden-Albala B, Buijs RM, Kreier F, Pickering TG, et al. Short sleep duration as a risk factor for hypertension: analyses of the first National Health and Nutrition Examination Survey. Hypertension. 2006;47:833-9.

Gottlieb DJ, Redline S, Nieto FJ, Baldwin CM, Newman AB, Resnick HE, Punjabi NM. Association of usual sleep duration with hypertension: the Sleep Heart Health Study. Sleep. 2006;29:1009-14.

Spiegel K, Knutson K, Leproult R, Tasali E, Van Cauter E. Sleep loss: a novel risk factor for insulin resistance and type 2 diabetes. J Appl Physiol. 2005;99:2008-15.

Nilsson PM, Roost M, Engstrom G, Hedblad B, Berglund G. Incidence of diabetes in middle-aged men is related to sleep disturbances. Diabetes Care. 2004;27:2464-9.